Search results for "Secondary prevention"
Continuing aspirin for no reason?
A speaker made the case for anticoagulant monotherapy in selected patients with stable coronary artery disease and atrial fibrillation during a “Things We Do For No Reason” session at SHM Converge 2022.
https://acphospitalist.acponline.org/archives/2022/04/27/continuing-aspirin-for-no-reason.htm
27 Apr 2022
For ACS patients, risk of repeat event high immediately after discharge
A follow-up analysis of patients hospitalized for acute coronary syndrome (ACS) found a greater than 40% risk of nonfatal myocardial infarction, nonfatal ischemic stroke, or cardiovascular death shortly after discharge, compared to a risk of only about 6% per year after one year.
https://acphospitalist.acponline.org/archives/2022/05/04/for-acs-patients-risk-of-repeat-event-high-immediately-after-discharge.htm
4 May 2022
New 8-item risk score may help predict ischemic events after ACS treated with PCI
Growth differentiation factor 15 and N-terminal pro–B-type natriuretic peptide were the best predictors of one-year risk of cardiovascular death or myocardial infarction among patients with acute coronary syndrome (ACS) who underwent percutaneous coronary intervention (PCI).
https://acphospitalist.acponline.org/archives/2022/10/26/new-8-item-risk-score-may-help-predict-ischemic-events-after-acs-treated-with-pci.htm
26 Oct 2022
Short-term dual antiplatelet therapy underused after mild stroke, study finds
While prescriptions of dual antiplatelet therapy after mild noncardioembolic stroke increased from 25.7% in 2010 to 52.8% in 2022 in 168 Florida hospitals, underuse remained common, especially in women and non-Hispanic Black patients.
https://acphospitalist.acponline.org/archives/2023/09/13/short-term-dual-antiplatelet-therapy-underused-after-mild-stroke-study-finds.htm
13 Sep 2023
Timing of stroke treatment, preventive therapies presented at stroke meeting
Mostly disappointing results on transfers for thrombectomy, delayed use of thrombolysis plus thrombectomy or tenecteplase, and anticoagulation for secondary prevention after cryptogenic stroke were reported at the International Stroke Conference.
https://acphospitalist.acponline.org/archives/2024/02/14/timing-of-stroke-treatment-preventive-therapies-presented-at-stroke-meeting.htm
14 Feb 2024